Spyder Cannabis Inc. (TSXV: SPDR) (“Spyder“), an established cannabis and vape retail operator intending to become one of North America’s leading hemp-infused medical and lifestyle company, today announced that it signed its first hemp agreement for the supply of full spectrum products to support Spyder’s debut of a hemp infused product line to be sold across the U.S. under its SPDR(R) brand.
Spyder is expanding its chain of hemp-infused medical and lifestyle product shops with their new brand called SPDR (R). These boutique shops will stock Spyder’s SPDR (R) branded hemp infused products developed for an aging, health and wellness demographic. Spyder will offer a wide array of hemp-infused product offerings including; muscle balm, face oil, body lotion and bath salts, as well as hemp-infused tinctures, capsules and sprays. In addition, hemp is a natural source of CBD, the non-intoxicating component of cannabis that can be used for health and wellness purposes in jurisdictions where legally permitted.
The hemp industry is booming and has the potential to become a $22 billion business by 2022, according to cannabis-focused research firm Brightfield Group. “Spyder plans on executing an aggressive expansion plan to create a significant retail brand in the U.S. hemp market,” stated Daniel Pelchovitz, CEO and President of Spyder. “We are very pleased to partner with this producer which will provide the product formulation and packaging to help create a premium product line for consumers across the U.S.”
The initial launch will feature four distinct hemp-derived products; Balms at 125mg and 500mg strength, tinctures at 300mg, 500mg and 1,000mg strength, soft gel capsules at 15mg strength and a pet line starting with tinctures at 300 mg strength.
About Spyder Cannabis
Founded in 2014 Spyder is an established chain of three high-end vape stores, and two cannabis accessory stores, in Ontario, with locations in Woodbridge, Scarborough, Burlington, Pickering and Niagara Falls. The Spyder brand is defined by its high-quality proprietary line of e-juice, liquids and exclusive retail deals, dispensed in uniquely designed stores creating the optimal customer experience. Spyder is building off this leading retail, distribution and branding eCig and vapes company and is pursuing expansion into the legal cannabis and hemp derived market. Spyder has developed a scalable retail model with plans to create a significant footprint with targeted and disciplined retail distribution strategy focusing on Canadian retail and U.S. boutique retail and kiosks in high traffic peripheral areas.
FOR ADDITIONAL INFORMATION, PLEASE CONTACT:
For more information, please contact:
Spyder Cannabis Inc. Dan Pelchovitz President & Chief Executive Officer Telephone: (905) 265-8273 Email: dan@spydervapes.com
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
This news release includes statements containing certain “forward-looking information” within the meaning of applicable securities laws (“forward-looking statements”). Forward-looking statements are frequently characterized by words such as “plan”, “continue”, “expect”, “project”, “intend”, “believe”, “anticipate”, “estimate”, “may”, “will”, “potential”, “proposed” and other similar words, or statements that certain events or conditions “may” or “will” occur..
These statements are only predictions. Various assumptions were used in drawing the conclusions or making the projections contained in the forward-looking statements throughout this news release. Forward-looking statements are based on the opinions and estimates of management at the date the statements are made. Any number of risks and uncertainties and other factors that could cause actual events or results to differ materially from those projected in the forward-looking statements.
OTC Markets Group Inc. (OTCQX: OTCM), operator of financial markets for 10,000 U.S. and global securities, today announced Vapen MJ Ventures Corporation (CSE: VAPN; OTCQX: VAPNF), a fully integrated agricultural technology, services and property management company in the cannabis industry, has qualified to trade on the OTCQX® Best Market.
Vapen MJ Ventures Corporation begins trading today on OTCQX under the symbol “VAPNF.” U.S. investors can find current financial disclosure and Real-Time Level 2 quotes for the company on www.otcmarkets.com.
“We are pleased to welcome Vapen MJ Ventures Corporation to the OTCQX Best Market,” said Jason Paltrowitz, EVP of Corporate Services at OTC Markets Group. “Trading on the OTCQX Market in the U.S., along with the company’s recent listing on the Canadian Securities Exchange, will enable Vapen MJ Ventures Corporation to build visibility and provide additional transparency for investors globally. We look forward to supporting the company in the public markets.”
Thai Nguyen, chief executive officer, and Bob Brilon, president and chief financial officer of Vapen MJ Ventures Corporation added, “We believe that Vapen MJ’s qualification for trading on OTCQX will increase awareness and visibility while providing transparency for our global investors. Vapen MJ is expanding its market penetration in the United States with partnerships in various additional states. Simultaneously, the company is expanding its presence with the financial community, and joining the prestigious international community of companies that trade on OTCQX and increasing access for U.S. investors is a key step in this effort.”
SecuritiesLawUSA, PC acted as the company’s OTCQX sponsor.
About Vapen MJ Ventures Corporation Vapen MJ Ventures Corporation, through its wholly-owned subsidiaries, currently operates as an agricultural technology, services and property management company utilizing a full vertical integration business model to oversee and execute all aspects of cultivation, extraction, manufacturing (THC and CBD cartridges, concentrates, edibles), retail dispensary, and wholesale distribution of high margin Cannabis THC and Hemp CBD products under the Vapen Brand. Vapen MJ currently provides these management and marketing services in the State of Arizona with expansion plans through acquisitions and partnerships worldwide. Vapen MJ expansion plans include partnering with cannabis license holders and hemp farms in multiple states within the U.S.
About OTC Markets Group Inc. OTC Markets Group Inc. (OTCQX: OTCM) operates the OTCQX® Best Market, the OTCQB® Venture Market and the Pink® Open Market for 10,000 U.S. and global securities. Through OTC Link® ATS and OTC Link ECN, we connect a diverse network of broker-dealers that provide liquidity and execution services. We enable investors to easily trade through the broker of their choice and empower companies to improve the quality of information available for investors.
To learn more about how we create better informed and more efficient markets, visit www.otcmarkets.com.
OTC Link ATS and OTC Link ECN are SEC regulated ATSs, operated by OTC Link LLC, member FINRA/SIPC.
During the last year, we have noticed a significant increase the amount of demand for cannabis infused products and are bullish on this vertical of the cannabis industry. Over the next year, we expect this trend to persist and believe that the companies that are levered to this opportunity are poised to report massive growth.
Plus Products (PLUS.CN) (PLPRF) is a company that has been benefiting from the increasing consumer demand for cannabis infused products and this is an opportunity that we have been closely following.
The last two months have been significant for the cannabis infused product company and we are bullish on the growth prospects on a going-forward basis. During this time, Plus Products announced the acquisition of California cannabis concentrate business and reported plans to expand into the Nevada market. We are favorable on the growth prospects associated with these initiatives and will monitor how the team continues to execute on this.
Las Vegas Represents a Massive Market for Plus Products
Las Vegas is one of the most important cannabis markets in the US and we are favorable on the leverage that Plus Products has to this market. On an annual basis, Las Vegas attracts more than 42 million tourists, and this has made Nevada a primetime destination for cannabis businesses. When a company is working to build a national (or global) brand, they need to be focused on several key markets. These markets are similar in the way that they attract tourists and bring the people to the brand.
In late May, Plus Products announced plans to expand into the Nevada market through a definitive agreement to partner with TapRoot Holdings, a vertically integrated cannabis company with cultivation and manufacturing facilities in Las Vegas. When it comes to selection a strategic partner, Plus Products conducts significant due diligence and believes that it can leverage TapRoot’s extraction capabilities as a part of a supply agreement. In addition to TapRoot’s extraction capabilities, it has also received 7 of the 61 newly issued retail licenses in late 2018.
Plus Products believes that TapRoot has the facilities available for the company to easily and quickly deploy its machinery, ingredients, and personnel to ensure that the product remains consistent both in California and Nevada. As the company expands into new markets, it will serve as the manufacturing operations partner to ensure quality and consistency across markets. We find this to be significant when it comes to creating a consistent product and are bullish on the growth prospects associated with this relationship.
We are favorable on the leverage that Plus Products will have to the Las Vegas opportunity and believe that it is a key market when it comes to building an internationally recognized brand. We are of the opinion that the move into Nevada is just the start of something much bigger and this is a something that we are excited about. During the last year, Plus Products has become the top selling edible in the California market (according to BDS Analytics) and we expect its products to perform very well in cannabis markets across the US.
A Company with Massive Growth Potential
Last month, Plus Products announced that it has acquired an option to purchase Emerald Bay Wellness LLC, a California-based cannabis oil manufacturer. The option grants the company the irrevocable right, but not the obligation, to purchase all of the business assets of Emerald Bay Extracts for cash and stock.
There are a number of reasons why we are excited about this transaction and will highlight this one-by-one. First, Emerald Bay Extracts is currently one of Plus’ largest suppliers of cannabis oil and has been a supply partner for over a year. Second, if the option is exercised, the acquisition would give the company in-house cannabis extraction capabilities that would both improve quality control and increase gross margins on the core edibles business, while creating a new revenue stream and new product development capabilities. Finally, this transaction will provide attractive leverage to a burgeoning opportunity in California where the market is rapidly shifting towards manufactured products that require cannabis oil.
Another reason why we are bullish on the implications that this acquisition will have on the business is due to the cost of the transaction. Approximately 70% of the deal consideration would be subject to performance targets including revenue and we find this to be significant when it comes to execution. We are favorable on the vesting schedule associated with the acquisition and believe that it could significant advance Plus Products’ business.
A Company that is in a Class of its Own
One of the reasons we are favorable on Plus Products is due to the type of investors that it has attracted. During the last year, the company has received large investments from some of the most significant hedge funds that are focused on the cannabis industry and this is a testament to the quality of the opportunity.
When it comes to Plus Products, we believe that the company is led by one of the best management teams in the business and are favorable on the additions that have been made to the team. Since inception, the management team has proven its ability to execute and we are bullish on this aspect of the story. We believe that the strength of the management team played a key role in the company’s ability to attract strategic capital and find this to be significant.
Going forward, Plus Products has massive growth prospects and this is an opportunity to be watching. The planned expansion in Nevada will prove to be a major value driver and we expect to see the company enter additional US markets in the coming months. To learn more about how Plus Products plans to be a leading cannabis infused product company, please email support@technical420.com.
Pursuant to an agreement between StoneBridge Partners LLC and PLUS Products Inc. we have been hired for a period of 180 days beginning March 21, 2019 and ending September 21, 2019 to publicly disseminate information about (PLUS) including on the Website and other media including Facebook and Twitter. We are being paid $5,000 per month (CASH) per month for services rendered. We own 106,000 shares of (PLUS), which we purchased in via private placement. We may buy or sell additional shares of (PLUS) in the open market at any time, including before, during or after the Website and Information, provide public dissemination of favorable Information. On November 1st 2018 StoneBridge Partners LLC sold 50,000 restricted shares of (PLUS) to a private investor via a direct sale.
Share
Authored By
Anthony Varrell
Anthony Varrell is Managing Director of StoneBridge Partners LLC. SBP continues to drive market awareness for leading firms in the cannabis industry throughout the U.S. and abroad.
1933 Industries Inc. (CSE: TGIF) (OTCQX: TGIFF), a vertically integrated cannabis consumer packaged goods company that owns licensed cultivation and manufacturing assets to support its brands, reports on its expanded cannabis extraction capabilities and provides an update regarding its hemp extraction facility.
Original AMA cultivation facility to be used for expanded extraction
The Company has commenced plans to utilize its original cultivation facility to increase its extraction capacity for concentrates. Concentrates such as shatter, crumble, sugar, wax, budder, and distillate are sold under the Alternative Medicine Association (AMA) brand and are available in licensed dispensaries throughout Nevada. Distillate is considered the cleanest, clearest and purest form of concentrate and yields high THC percentages. Well-known for its top-quality concentrates, AMA extracts its distillate by using a hydrocarbon extraction process. The Company has made preparations to complete tenant improvements on the building in order to expand its concentrate production area from 483 sq. ft. to 2,215 sq. ft. in the current facility. The expected distillate production capacity will increase from 40 litres per month to 80 litres per month, in order to secure the supply for its branded products as well as for its white label partners.
Once the plants are moved to the new cultivation facility, the Company expects to submit layout plans to the city of Las Vegas for permitting and commence tenant improvements on the original cultivation facility. The necessary extraction equipment has been sourced and will also be submitted to the state for approval. The Company expects the expanded operation to come online in the fall of 2019.
“This is another exciting development for the Company as we increase production of raw materials for our line of concentrates. We are growing, expanding and investing in infrastructure for the growth of our brands,” said Ms. Ester Vigil, President of the Company.
Hemp extraction facility will be one of a kind
The Company reports that it has been working with an engineering firm to customize the equipment that will be required to establish one of Nevada’s largest hemp extraction facilities, with increased output capacity and versatility for isolation of CBD, CBN, CBG, CBC, and several other cannabinoids, including the ability to produce full spectrum and broad-spectrum oils, as well as isolates, that meet required GMP standards.
Mr. Chris Rebentisch, CEO of the Company remarked, “The process has been scaled up after a lengthy research phase, where we aimed to create a method of extraction using specialized chemistry and equipment in order to obtain a higher yield of CBD, thus increasing our efficiency. The competitive advantage of the new facility will be the isolation of not only CBD but of additional individual cannabinoids at scale, which is unique and novel in the cannabis marketplace.”
He added, “The research phase served to engineer and customize our proprietary equipment for the desired scale of the pilot plant, therefore meeting the unique needs of our business. We believe that the capital investment we are making today will have the benefits of lowering our operating and manufacturing costs, increasing cannabinoid extraction efficiency with a higher recapture rate, and bringing higher returns for years to come.”
The Company has ordered its customized equipment and is working on the final layout of the facility and will commence tenant improvements once the floor plan and layout has received approval from the city of Las Vegas. Permitting has been completed for fire and city inspections as well as H-3 hazard zoning. Because the customized equipment requires a long lead time, the Company expects that the facility will be operational by year’s end.
The facility’s processing capacity is estimated at approximately 68,000 kgs. of hemp biomass or 150,000 lbs. per month, producing approximately 5,000 kgs. of full spectrum oils or 4,500 kgs. of CBD isolate.
About 1933 Industries Inc. 1933 Industries Inc. is a vertically integrated cannabis company with operations in the United States and Canada. 1933 Industries owns licensed medical and adult-use cannabis cultivation and production assets, proprietary hemp-based, CBD infused products, and CBD extraction services. Our proprietary brands include AMA, Canna Hemp™, Canna HempX™, Canna Fused™, Canna Hemp Paws™, and Nineteen 33 THC. Birdhouse Skateboards™, OG DNA Genetics, Denver Dab Co., The Real Kurupt’s Moon Rocks and Gotti’s Gold are under licensing agreements.
About Canna Hemp™ Canna Hemp™ CBD Relief Cream was named “Best Topical” by Leafy’s Best in State: The Top State Specific Products and Experiences of 2018. Infused’s award-winning transdermal Pain Relief Cream delivers fast-acting targeted relief to areas of discomfort, combating inflammation, arthritis joint pain, backaches, muscles spasms, strains, bruises, cramps, and headaches. http://www.cannahemp.com https://www.leafly.com/news/strains-products/best-in-state-2018-nevada-cannabis
About Canna HempX™ Canna Hemp X™ was named “Best Topicals for Pain” by Herb’s Guide to the Best Cannabis Products on the Planet. Canna Hemp X™ is a CBD sports recovery cream for athletes to help focus on recovery and wellness. From soothing pain, aiding with muscle spasms, healing assistance for bruises, injuries, or arthritis relief, Canna Hemp X™ bridges the gap between recovery and top performance. http://www.cannahempx.com
Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.
Notice regarding Forward Looking Statements: This news release contains forward-looking statements. The use of any of the words “anticipate”, “continue”, “estimate”, “expect”, “may”, “will”, “project”, “should”, “believe” and similar expressions are intended to identify forward-looking statements. Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this news release. Actual results could differ materially from those currently anticipated due to a number of factors and risks including various risk factors discussed in the Company’s disclosure documents, which can be found under the Company’s profile on www.sedar.com. 1933 Industries undertakes no obligation to update publicly or revise any forward-looking information, whether as a result of new information, future events or otherwise, except as required by law.
Aleafia Health Inc. (TSX: ALEF, OTC: ALEAF, FRA: ARAH) has been added to The Cannabis ETF (NYSE: THCX) (“THCX”), which trades on the New York Stock Exchange. THCX seeks to track the Innovation Labs Cannabis Index which is a portfolio of 35 stocks expected to benefit from growth of the legal marijuana, CBD and hemp industries.
“Aleafia Health welcomes the increased exposure to U.S. investors resulting from our addition to The Cannabis ETF,” said Aleafia Health CEO Geoffrey Benic. “This innovative ETF will serve as an important new avenue to tell the story of our highly differentiated global cannabis and wellness business.”
Aleafia Health is a leading, vertically integrated cannabis health and wellness company with four primary business units: Cannabis Cultivation & Products, Health & Wellness Clinics, Cannabis Education, and Consumer Experience with ecommerce, retail distribution and provincial supply agreements.
Aleafia Health owns three major cannabis product & cultivation facilities, two of which are licensed and operational including the first large-scale, operational outdoor cultivation facility in Canadian history. The Company produces a diverse portfolio of commercially proven, high-margin derivative products including oils, capsules and sprays. Aleafia Health operates the largest national network of medical cannabis clinics and education centres staffed by MDs, nurse practitioners and educators and has international operations in three continents.
Innovation is at the heart of Aleafia Health competitive advantage. The Company maintains a medical cannabis dataset with over 10 million data points to inform proprietary illness-specific product development and its highly differentiated education platform FoliEdge Academy. The Company is committed to creating sustainable shareholder value and has been named the 2019 top performing company of the year by the TSX Venture Exchange prior to graduation to the TSX.
Forward Looking Information
This news release contains forward-looking information within the meaning of applicable Canadian and United States securities laws. Often, but not always, forward-looking information can be identified by the use of words such as “plans”, “expects” or “does not expect”, “is expected”, “estimates”, “intends”, “anticipates” or “does not anticipate”, or “believes” or variations of such words and phrases or state that certain actions, events or results “may”, “could”, “would”, “might” or “will” be taken, occur or be achieved. Forward-looking information involves known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the Company or its subsidiaries to be materially different from any future results, performance or achievements expressed or implied by the forward-looking information contained in this news release. Risks, uncertainties and other factors involved with forward-looking information could cause actual events, results, performance, prospects and opportunities to differ materially from those expressed or implied by such forward-looking information, including risks contained in the Company’s annual information form filed with Canadian securities regulators available on the Company’s SEDAR profile at www.sedar.com. Although the Company believes that the assumptions and factors used in preparing the forward-looking information in this news release are reasonable, undue reliance should not be placed on such information and no assurance can be given that such events will occur in the disclosed time frames or at all. The forward-looking information included in this news release are made as of the date of this news release and the Company does not undertake any obligation to publicly update such forward-looking information to reflect new information, subsequent events or otherwise unless required by applicable securities legislation.
Share
Authored By
Anthony Varrell
Anthony Varrell is Managing Director of StoneBridge Partners LLC. SBP continues to drive market awareness for leading firms in the cannabis industry throughout the U.S. and abroad.
Next Green Wave Holdings Inc. (CSE: NGW) (OTCQX: NXGWF) is pleased to announce it is launching another exclusive line of products with California-based artist Sketchy Tank and his distinctive apparel and accessory brand Lurking Class. This branding partnership will enable Next Green Wave to break into a segment of cannabis consumers that Lurking Class has cultivated for over a decade.
Sketchy Tank’s artwork and clothing are currently sold at over 700 stores across the United States including the leading specialty retailer Zumiez. His artwork has been featured in several multinational brands like Vans and upcoming Brand House HQ located in San Diego. His new artwork will be featured on limited collectable packaging on selected cannabis oil products launching in partnership with NGW this month.
“Lurking Class by Sketchy Tank has a considerable following and this affiliation will help our products to reach a consumer base that would otherwise be more difficult to penetrate as a more recent entrant in the cannabis market,” stated CEO and Executive Director, Leigh Hughes. “This partnership, through our subsidiary SDC, makes it possible for us to establish a presence among consumers who have already expressed keen interest in the products that we will soon deliver.”
“From our humble beginnings, our work with SDC and the values and respect that we share have made this progression inevitable. I look forward to a long and continuing association with the SDC and NGW teams as we grow the Lurking Class and Sketchy Tank brands together with the complementary products and brands which will soon become available from NGW. This is an incredible and exciting fit.” -Commented Sketchy Tank.
Sketchy Tank, the Balaclava hooded fiend, and pioneering artist of global brand Lurking Class, is back doing what he does best. From the early beginnings of “sketchy material” on the internet, to collaborations with international street lifestyle brands, his growing visibility to those that choose to walk another path continues to fuel the fire that runs deep.
About Next Green Wave
NGW is a California based full-service premium cannabis producer in both the wellness and recreational market. The Company is now in production and rolling out over 45 products through its subsidiary SDC Ventures LLC and 8 major partner brands. NGW has four core business segments: CBD/THC nursery, cultivation, extraction, and distribution. Primary facilities are situated in Coalinga, where the company holds over 15 Acres of cannabis-zoned land and is actively expanding operations. NGW has a seed library of over 120 strains which include multiple award-winning genetics and cultivars. The investment in OMG3 will provide NGW further access to distribution throughout Colombia. To find out more visit us at www.nextgreenwave.comor follow us on Twitter, Instagram, or LinkedIn.
On behalf of the board,
Leigh Hughes, CEO and Executive Chairman Next Green Wave Holdings Inc.
For more information regarding Next Green Wave, contact:
Caroline Klukowski VP Corp. Development Tel: +1 (778) 589-2848 IR@nextgreenwave.com
Next Green Wave Forward Looking Statements
This press release contains forward-looking statements within the meaning of applicable securities laws. All statements that are not historical facts, including without limitation, statements regarding future estimates, plans, programs, forecasts, projections, objectives, assumptions, expectations or beliefs of future performance, are “forward-looking statements.” Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause actual results, events or developments to be materially different from any future results, events or developments expressed or implied by such forward looking statements. Such risks and uncertainties include, among others, the risk factors included in the preliminary prospectus, including without limitation dependence on obtaining and maintaining regulatory approvals, including acquiring and renewing state, local or other licenses and any inability to obtain all necessary governmental approvals licenses and permits to complete construction of its proposed facilities in a timely manner; engaging in activities which currently are illegal under US federal law and the uncertainty of existing protection from U.S. federal or other prosecution; regulatory or political change such as changes in applicable laws and regulations, including U.S. state-law legalization, particularly in California, due to inconsistent public opinion, perception of the medical-use and adult-use marijuana industry, bureaucratic delays or inefficiencies or any other reasons; any other factors or developments which may hinder market growth; NGW’s limited operating history and lack of historical profits; reliance on management; NGW’s requirements for additional financing, and the effect of capital market conditions and other factors on capital availability, including closing of Tranche 1 and Tranche 2 of the Notes; competition, including from more established or better financed competitors; and the need to secure and maintain corporate alliances and partnerships, including with customers and suppliers. Readers are encouraged to the review the section titled “Risk Factors” in NGW’s prospectus. These factors should be considered carefully, and readers are cautioned not to place undue reliance on such forward-looking statements. Although NGW has attempted to identify important risk factors that could cause actual actions, events or results to differ materially from those described in forward-looking statements, there may be other risk factors that cause actions, events or results to differ from those anticipated, estimated or intended. There can be no assurance that forward-looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in forward-looking statements. NGW no obligation to update any forward-looking statement, even if new information becomes available as a result of future events, new information or for any other reason except as required by law.
Click on, or paste the following link into your web browser,to view the associated documents http://www.newsfilecorp.com/release/46145
Share
Authored By
Anthony Varrell
Anthony Varrell is Managing Director of StoneBridge Partners LLC. SBP continues to drive market awareness for leading firms in the cannabis industry throughout the U.S. and abroad.
Today, CannTrust Holdings Inc. (“CannTrust” or the “Company”, TSX: TRST, NYSE: CTST) announced an update on its outdoor cultivation operation in British Columbia and its first shipment of capsule and dry flower products to Australia.
Outdoor Cultivation Update
After closing the purchase of its first 81 acres of land in British Columbia for outdoor cannabis cultivation, CannTrust immediately invested in fencing, security, irrigation and other land preparation activities and applied for Health Canada approval to plant and cultivate on the land. Based on its estimate of yields and projected date of permitting at the time, CannTrust estimated 75,000kg of cannabis could be produced from this property in 2019. As CannTrust has yet to receive its Health Canada permit at this stage of the growing season, it is now estimated that production from this operation could range from 0 to 15,000kg in 2019, subject to the timing and receipt of regulatory approvals. A crop of up to 15,000kg is expected if planting is completed in the first half of July 2019 and yields will diminish if a crop is planted in the second half of the month. If a crop is not planted by August 5, 2019, there will be no outdoor harvest in 2019.
CannTrust expects to reach a definitive agreement for a long-term lease for an additional 160 acres in the near term and that all properties, representing over 240 acres of land, will be prepared for planting at the beginning of the growing season in 2020. Between these two properties, CannTrust continues to expect that it can produce between 100,000kg to 200,000kg of cannabis in British Columbia in 2020, subject to regulatory approvals.
“We have access to premium land in a very rich agricultural region and we remain undeterred in our long-term strategy to develop innovative cannabis products at low cost,” said Peter Aceto, Chief Executive Officer.
First Shipment to Australia
Last week, CannTrust completed its first shipment of CBD, THC and 1:1 CBD:THC vegan capsules and dry flower products to Australia. These products will be resold by its partner Cannatrek Ltd. (“Cannatrek”) to medical patients in Australia. These shipments are expected to continue until Cannatrek’s operations achieve commercial production. CannTrust now has nine products available to medical patients in Australia.
“The first steps to build CannTrust’s global footprint were established last year through partnerships in Europe and Australia. We continue to make excellent progress with our partners in these regions as they build their operations and through our regular shipments of our award-winning products to both Denmark and Australia. We will continue taking action to establish leading positions in medical cannabis markets around the world. CannTrust is in an excellent position to increase our international business as medical and recreational cannabis continue to gain acceptance worldwide,” said Peter Aceto.
About CannTrust
CannTrust is a federally regulated licensed producer of medical and recreational cannabis in Canada. Founded by pharmacists, CannTrust brings more than 40 years of pharmaceutical and healthcare experience to the medical cannabis industry and serves more than 72,000 medical patients with its dried, extract and capsule products. The Company operates its Niagara Perpetual Harvest Facility in Pelham, Ontario, and prepares and packages its product portfolio at its manufacturing centre of excellence in Vaughan, Ontario. The Company has also purchased 81 acres of land in British Columbia and expects to secure over 240 acres of land in total for low-cost outdoor cultivation which it will use for its extraction-based products.
Forward Looking Statements
This press release contains “forward-looking information” within the meaning of Canadian Securities laws and “forward-looking statements” within the meaning of the United States Private Securities Litigation Reform Act of 1995 and other applicable United States safe harbor laws, and such statements are based upon CannTrust’s current internal expectations, estimates, projections, assumptions and beliefs and views of future events. Forward-looking information and forward-looking statements can be identified by the use of forward-looking terminology such as “believes”, “expect”, “likely”, “may”, “will”, “should”, “intend”, “anticipate”, “potential”, “proposed”, “estimate” and other similar words, including negative and grammatical variations thereof, or statements that certain events or conditions “may”, “would” or “will” happen, or by discussions of strategy. The forward-looking information and statements in this news release include statements relating to the Company’s plans to obtain regulatory approval for outdoor cultivation and estimates on yield for the 2019 growing season, and the shipment of capsule and dry flower products to Cannatrek in Australia. Forward-looking information and statements necessarily involve known and unknown risks, including, without limitation: obtaining regulatory approval; risks associated with general economic conditions; adverse industry events; loss of markets; future legislative and regulatory developments in Canada, the United States and elsewhere; the cannabis industry in Canada generally; and, the ability of CannTrust to implement its business strategies. Any forward-looking information and statements speak only as of the date on which they are made, and, except as required by law, CannTrust does not undertake any obligation to update or revise any forward-looking information or statements, whether as a result of new information, future events or otherwise. New factors emerge from time to time, and it is not possible for CannTrust to predict all such factors. When considering these forward-looking information and statements, readers should keep in mind the risk factors and other cautionary statements in CannTrust’s Annual Information Form dated March 28, 2019 (the “AIF”) and filed with the applicable Canadian securities regulatory authorities on SEDAR at www.sedar.com and filed as an exhibit CannTrust’s Form 40-F annual report under the United States Securities Exchange Act of 1934, as amended, with the United States Securities and Exchange Commission on EDGAR at www.sec.gov. The risk factors and other factors noted in the AIF could cause actual events or results to differ materially from those described in any forward-looking information or statements. The TSX and NYSE do not accept responsibility for the adequacy or accuracy of this release.
or to arrange an interview, please contact: Media Relations: Riya Dhaliwal, Tel: 1-888-677-1477, media@canntrust.ca; Investor Relations: Marc Charbin, 416-467-5229, investor@canntrust.caCopyright CNW Group 2019
Next Green Wave Holdings Inc. (CSE: NGW) (OTCQX: NXGWF) (“Next Green Wave”, “NGW” or the “Company”) is pleased to announce it is launching its next exclusive cannabis product line with influential illustrator and artist Junkyard, through its subsidiary SDC Ventures LLC. The launch is part of the Company’s strategic plan to secure distribution and introduce its brands and products to the California market as it enters into revenue.
Junkyard is a well-known illustrator and street artist with an established social and digital reach of enthusiasts who follow his artwork throughout California and the United States. The first product to launch will be an oil extraction with limited release collectable packaging designed by the artist himself. Additional apparel releases and live painting appearances catering to craft cannabis culture will be announced throughout Southern California this summer.
Next Green Wave CEO and Executive Director, Leigh Hughes stated: “We’re thrilled to be working with Junkyard and believe his loyal fanbase and individual brand will add further strong impetus to our growth and give us wider access potential to a niche consumer looking for distinguished and quality-based cannabis products.”
“We launched the Junkyard Cannabis brand with NGW and SDC as an extension of what is already happening in our fanbase. As a large portion of our fanbase are cannabis fans and consumers, it was a natural next step. Our team is excited to finally launch a premium brand with NGW and SDC. We have been looking for a partner that has the same aesthetic and attention to detail in their craft. It has been a fantastic process working alongside their team. Look out soon for products in California legal dispensaries.” Commented Junkyard.
Junkyard is an illustrator and street artist who was born and raised in South Africa now splitting his time between Chicago and LA. Known for some of his larger than life black and white murals and clothing, he has teamed up with some of the biggest brands in the game including Disney. His Instagram account took off after he installed a mural at Threadless HQ in Chicago and began to sell T-Shirts to fans. No one knows what he looks like, which adds to the mystery behind the brand and brings focus to the art he produces. His distinct style and passion for craft high end concentrates will fill a gap in the market.
About Next Green Wave
NGW is a California based full-service premium cannabis company in the medical and recreational market. The Company’s first state-of-the-art facility (35,000 ft.2) is in production and expansions on the 15 acres cannabis zoned land it is situated on are underway. NGW has a seed library of over 120 strains which include multiple award-winning genetics and cultivars. Recent acquisition of SDC and affiliates will provide NGW with significant exposure and distribution points throughout California. The investment in OMG3 will provide NGW further access to distribution throughout Colombia. To find out more visit us at www.nextgreenwave.comor follow us on Twitter, Instagram, or LinkedIn.
On behalf of the board,
Leigh Hughes, CEO and Executive Chairman Next Green Wave Holdings Inc.
For more information regarding Next Green Wave, contact: Caroline Klukowski VP Corp. Development Tel: +1 (778) 589-2848 IR@nextgreenwave.com
Next Green Wave Forward Looking Statements
This press release contains forward-looking statements within the meaning of applicable securities laws. All statements that are not historical facts, including without limitation, statements regarding future estimates, plans, programs, forecasts, projections, objectives, assumptions, expectations or beliefs of future performance, are “forward-looking statements.” Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause actual results, events or developments to be materially different from any future results, events or developments expressed or implied by such forward looking statements. Such risks and uncertainties include, among others, the risk factors included in the preliminary prospectus, including without limitation dependence on obtaining and maintaining regulatory approvals, including acquiring and renewing state, local or other licenses and any inability to obtain all necessary governmental approvals licenses and permits to complete construction of its proposed facilities in a timely manner; engaging in activities which currently are illegal under US federal law and the uncertainty of existing protection from U.S. federal or other prosecution; regulatory or political change such as changes in applicable laws and regulations, including U.S. state-law legalization, particularly in California, due to inconsistent public opinion, perception of the medical-use and adult-use marijuana industry, bureaucratic delays or inefficiencies or any other reasons; any other factors or developments which may hinder market growth; NGW’s limited operating history and lack of historical profits; reliance on management; NGW’s requirements for additional financing, and the effect of capital market conditions and other factors on capital availability, including closing of Tranche 1 and Tranche 2 of the Notes; competition, including from more established or better financed competitors; and the need to secure and maintain corporate alliances and partnerships, including with customers and suppliers. Readers are encouraged to the review the section titled “Risk Factors” in NGW’s prospectus. These factors should be considered carefully, and readers are cautioned not to place undue reliance on such forward-looking statements. Although NGW has attempted to identify important risk factors that could cause actual actions, events or results to differ materially from those described in forward-looking statements, there may be other risk factors that cause actions, events or results to differ from those anticipated, estimated or intended. There can be no assurance that forward-looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in forward-looking statements. NGW no obligation to update any forward-looking statement, even if new information becomes available as a result of future events, new information or for any other reason except as required by law.
1933 Industries Inc. (the “Company” or “1933 Industries”) (CSE: TGIF) (OTCQX: TGIFF), a vertically integrated cannabis consumer packaged goods company that owns licensed cultivation and manufacturing assets to support its brands, is pleased to announce that the Company received a permanent Occupancy Permit for its cultivation facility, thereby completing the last step of the construction project initiated to expand cannabis cultivation in Las Vegas, Nevada.
“The completion of our new cultivation facility marks an incredible milestone for our Alternative Medicine Association (AMA) subsidiary”, said Company CEO Mr. Chris Rebentisch. “We are extremely pleased to be able to move into our new facility and begin operations. This is a 5x increase in flower cultivation to fuel the growth of our proprietary AMA branded products and deliver on our white label contracts. Securing a consistent supply of raw materials will have a positive effect on our margins and future revenues and will enable us to attract additional partners.”
Facility Highlights
Total Size: The 67,750 sq. ft. building is spread over two floors and is zoned as a Light Manufacturing – M-1 facility. This will be one of the largest indoor facilities in Las Vegas.
Cultivation Space: The facility was designed to house 15 bloom rooms, 3 veg rooms and 1 clone room. The initial operating canopy will be 22,100 sq. ft. with the ability to expand into another 18,000 sq. ft., if needed.
Cultivation Cycle: On average, the grow cycle is approximately 15 weeks. Once capacity is reached with all 15 flower rooms filled, the Company expects to harvest approximately 1,500 plants every 14 days for a projected 700-800 lbs. of flower per month.
Fertigation System: A Link 4 system controls mixing nutrients (mixing up to 15 different nutrients automatically) and plant watering to each room, according to a pre-defined formula, corresponding to each growth stage. The system controls HVAC, humidification and dehumidification, and oxygen levels with built-in safety alarms in each grow room.
Mr. Tim Spencer, Director of Cultivation remarked, “Link 4 integrates all the environmental systems, allowing us to track all input data points in the cultivation process. We can then drive our crops with data rather than subjective opinions and truly maximize the potential of the facility”.
Consistent Water Supply: The facility includes a 12,000gal Reverse Osmosis Storage system. This feature is significant as the Las Vegas municipal water has a high mineral content and cultivating with clean water is essential for plant health. In addition, the volume of water stored allows the Company to mitigate the risk of a service interruption.
Plant Health and Disease Management: The HVAC System (a Daikin Variable Refrigerant Volume) multi-split air conditioner allows each room to function independently, with no duct-work built between grow rooms. Having a true “sealed” room increases Co2 levels without waste and allows for effective plant quarantining should a disease outbreak arise.
Lighting System: An eFinity 1,100w DEHPS dimmable electronic ballast – from 1,000w to 600w – provides better control of the light spectrum for each stage of the plant. Utilizing a lighting controller provides the ability to ramp up the light intensity in the morning to mimic a natural “sunrise” and slowly turn down the light towards “sunset”, thus giving the plants a more natural lighting pattern and producing the largest yields possible.
Next Steps
Upon securing the transfer of its cultivation license to the new facility, 26 plant varieties, 5,000 clones, and 200 moms will be transported to propagate the new facility and commence operations.
1933 Industries Inc. is a vertically integrated cannabis company with operations in the United States and Canada. 1933 Industries owns licensed medical and adult-use cannabis cultivation and production assets, proprietary hemp-based, CBD infused products, CBD extraction services and a specialized cannabis advisory firm. Our proprietary brands include AMA, Canna Hemp™, Canna HempX™, Canna Fused™, Canna Hemp Paws™, and Nineteen 33 THC. Birdhouse Skateboards™, OG DNA Genetics, Denver Dab Co., The Real Kurupt’s Moon Rocks and Gotti’s Gold under licensing agreements.
About Canna Hemp™ Canna Hemp™ CBD Relief Cream was named “Best Topical” by Leafy’s Best in State: The Top State Specific Products and Experiences of 2018. Infused’s award-winning transdermal Pain Relief Cream delivers fast-acting targeted relief to areas of discomfort, combating inflammation, arthritis joint pain, backaches, muscles spasms, strains, bruises, cramps, and headaches. http://www.cannahemp.com https://www.leafly.com/news/strains-products/best-in-state-2018-nevada-cannabis
About Canna HempX™ Canna Hemp X™ was named “Best Topicals for Pain” by Herb’s Guide to the Best Cannabis Products on the Planet. Canna Hemp X™ is a CBD sports recovery cream for athletes to help focus on recovery and wellness. From soothing pain, aiding with muscle spasms, healing assistance for bruises, injuries, or arthritis relief, Canna Hemp X™ bridges the gap between recovery and top performance. http://www.cannahempx.com
Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.
Notice regarding Forward Looking Statements: This news release contains forward-looking statements. The use of any of the words “anticipate”, “continue”, “estimate”, “expect”, “may”, “will”, “project”, “should”, “believe” and similar expressions are intended to identify forward-looking statements. Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this news release. Actual results could differ materially from those currently anticipated due to a number of factors and risks including various risk factors discussed in the Company’s disclosure documents, which can be found under the Company’s profile on www.sedar.com. 1933 Industries undertakes no obligation to update publicly or revise any forward-looking information, whether as a result of new information, future events or otherwise, except as required by law.
Further to its news releases dated March 26 and April 4, 2019, Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA), a leading Colombia based licensed producer of medicinal cannabis and cannabis-derived products, is pleased to announce that the Company has entered into a definitive share purchase agreement to acquire cannabis cultivation, processing, manufacturing and other rights in Argentina from BBV Labs Inc.. Pursuant to a definitive joint venture agreement with the Argentinean state-owned company Cannabis Avatara, S.E., BBV Labs entered into a joint venture with Cannava to develop and cultivate cannabis on a 3.2 million square foot (74 acres or 30 hectares) prime agricultural property. Cannava will contribute the land to the Joint Venture as well as all required permits and authorization necessary to import seeds, cultivate, grow and harvest cannabis, process cannabis and extract cannabis oil and other derivative products for scientific, medicinal and therapeutic purposes and to export cannabis and derivative products and import and export related equipment and products.
“The signing of a definitive purchase agreement marks an important milestone in our entrance to the Argentinian market,” stated Camilo Villalba, Chief Operating Officer. “Being one of the first movers to have an arrangement like this in a country with a population of over 44 million people represents an extremely unique opportunity for Blueberries. We are working diligently to expedite build-out of our operations in Argentina, in addition to our continued commitment to our ideally located, low cost production operations in Colombia.”
“This agreement moves us another step closer to bringing this project to fruition, pioneering commercial cannabis production in Argentina,” stated Gaston Morales, the President of Cannava. “The Blueberries team have proven to be valuable partners, contributing leading operational expertise in cultivation, genetics, extraction and formulation. We look forward to continuing to work with them to move this exciting project forward.”
Highlights Include:
Blueberries gains rights to cannabis licenses in Argentina; amongst very few such agreements currently in place to supply cannabis products to the Argentinian population exceeding 44 million people. Also expands production footprint internationally and may provide additional export opportunities to other countries with evolving cannabis regulations.
Blueberries to build a large-scale modern cultivation facility and processing centre of excellence in Argentina.
Cannava will contribute all licenses/permits and authorization necessary to import seeds, cultivate, grow and harvest cannabis, process cannabis, extract cannabis oil and other derivative products, export cannabis and derivative products, and import/export equipment and products.
Cannava will grant access to utilize 3.2 million square feet (74 Acres or 30 hectares) of prime agricultural land for the cultivation and growth of cannabis in Jujuy Province, Argentina, ideally situated in an area with robust modern infrastructure including fresh water and modern power supply and a nearby airport, with additional land available for potential future expansion
Cannava will contribute all cooperation agreements with the National Institute of Agricultural Technology (INTA), Ministry of Security, Ministry of Public Health, National Council of Scientific and Technological Investigations (CONICET) and other regulatory and technological Argentinian authorities as required
Argentina’s relatively nascent cannabis industry began in 2017 with the legalization of cannabis for prescribed medical use. To date Cannava is the only entity authorized to cultivate and produce cannabis and derivatives in Argentina and Blueberries is among the first and limited number of companies to have such an arrangement with Cannava.
The 3.2 million square foot site is located on agricultural property in the province of Jujuy. The area is located in an ideal, temperate climate that permits year-round cultivation as well as a skilled and efficient agricultural labor force. The area is an established agricultural site with an operating history of over 100 years. The property is fed by multiple rivers providing ample access to fresh water for irrigation. The power supply is modern and has capacity to scale as production capacity is increased. With an international airport only 8km away, it is also as an ideal hub for import and export. The recent authorization of the site as Argentina’s first, and potentially on of the world’s largest cannabis farm and is expected to pave the way for a new industry in Argentina.
The first phase of the Joint Venture will be a Pilot Cultivation Program consisting of the preparation and cultivation of cannabis on a 107,000 square foot (1 hectare) area on public lands provided by Cannava with the goal of potentially producing 4 million grams (4,000 kg) of dry cannabis flower. The Pilot Project will also evaluate and characterize cannabis seeds and strains that are ideal for the climate conditions of Jujuy, and document the proposed operating procedures, technical processes, strains and products that the Joint Venture is seeking to produce. The Company has prepared a proposed Pilot Project plan for Cannava’s approval and processing of the applications for the permits as required, with the goal of completing the Pilot Program by May 2020.
Terms of the Transaction
Pursuant to the terms of the Share Purchase Agreement, Blueberries will acquire BBV Labs, and in turn, 75% of BBV Labs’ rights under the Joint-Venture with Cannava. As consideration for its interest, Blueberries will issue 16,000,000 common shares to the vendors of BBV Labs. Closing of the transaction is expected to occur in July.
Pursuant to the Joint Venture Agreement, proceeds from the manufacture and distribution activities, and from the cultivation and growth activities, will be distributed between BBV Labs (to be acquired by Blueberries) and Cannava, . Blueberries will be responsible for providing the expertise and capital required to operate and develop the Joint Venture operation. The Share Purchase Agreement was negotiated at arm’s length.
About Blueberries Medical Corp. Blueberries is a Latin American licensed producer of naturally grown premium quality cannabis with its primary operations ideally located in the Bogotá Savannah of central Colombia and operations currently being established in Argentina. The Company is led by a specialized team with proprietary expertise in agriculture, genetics, extraction, medicine, pharmacology and marketing, Blueberries is fully licensed for the cultivation, production, domestic distribution, and international export of CBD and THC-based medical cannabis in Colombia. Blueberries’ combination of leading scientific expertise, agricultural advantages and distribution arrangements has positioned the Company to become a leading international supplier of naturally grown, processed, and standardized medicinal-grade cannabis oil extracts and related products.
Additional information about the Company is available at www.blueberriesmed.com. For more information, please contact:
Cautionary Note Regarding Forward-Looking Information This news release contains “forward-looking information” and “forward-looking statements” (collectively, “forward looking statements”) within the meaning of the applicable Canadian securities legislation. All statements, other than statements historical fact, are forward-looking statements and are based on expectations, estimates and projections as at the date of this news release. Any statement that involves discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, assumptions, future events or performance (often but not always using phrases such as “expects”, or “does not expect”, “is expected”, “anticipates” or “does not anticipate”, “plans”, “budget”, “scheduled”, “forecasts”, “estimates”, “believes” or “intends” or variations of such words and phrases or stating that certain actions, events or results “may” or “could”, “would”, “might” or “will” be taken to occur or be achieved) are not statements of historical fact and may be forward-looking statements. In this news release, forward looking statements relate, among other things, to: closing of the proposed acquisition of BBV Labs, successful completion of the Phase 1 program with respect to the Joint Venture, internal expectations, expectations regarding the ability of the Company to expand its cultivation facilities and access new Latin American markets, including, without limitation, access to free-trade zone markets, and access to export cannabis products to Brazil and Chile, the ability to attract and retain new customers, and future expansion plans including development of the cultivation, production, industrialization and marketing of cannabis for scientific purposes related to the proposed Joint Venture.
These forward-looking statements are based on reasonable assumptions and estimates of management of the Company at the time such statements were made. Actual future results may differ materially as forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the Company to materially differ from any future results, performance or achievements expressed or implied by such forward-looking statements. Such factors, among other things, include: fluctuations in general macroeconomic conditions; fluctuations in securities markets; expectations regarding the size of the Colombian and international medical cannabis market and changing consumer habits; the ability of the Company to successfully achieve its business objectives; plans for expansion; political and social uncertainties; inability to obtain adequate insurance to cover risks and hazards; and the presence of laws and regulations that may impose restrictions on cultivation, production, distribution and sale of cannabis and cannabis related products in Colombia or internationally; and employee relations. Although the forward-looking statements contained in this news release are based upon what management of the Company believes, or believed at the time, to be reasonable assumptions, the Company cannot assure shareholders that actual results will be consistent with such forward-looking statements, as there may be other factors that cause results not to be as anticipated, estimated or intended. Readers should not place undue reliance on the forward-looking statements and information contained in this news release. The Company assumes no obligation to update the forward-looking statements of beliefs, opinions, projections, or other factors, should they change, except as required by law.
Additional information regarding the Company, and other risks and uncertainties relating to the Company’s business are contained under the heading “Risk Factors” in the Company’s Listing Statement dated January 31, 2019 filed on its issuer profile on SEDAR at www.sedar.com.
No stock exchange, securities commission or other regulatory authority has approved or disapproved the information contained herein.
View original content to download multimedia:
View original content to download multimedia:
View original content to download multimedia: 
View original content to download multimedia:
View original content to download multimedia: